0001209191-14-007834.txt : 20140206
0001209191-14-007834.hdr.sgml : 20140206
20140206085327
ACCESSION NUMBER: 0001209191-14-007834
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140205
FILED AS OF DATE: 20140206
DATE AS OF CHANGE: 20140206
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 252025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-9911
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 400
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TRV GP, LLC
CENTRAL INDEX KEY: 0001578973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 14578149
BUSINESS ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Third Rock Ventures GP, L.P.
CENTRAL INDEX KEY: 0001578976
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 14578150
BUSINESS ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: C/O THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THIRD ROCK VENTURES LP
CENTRAL INDEX KEY: 0001408591
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 14578151
BUSINESS ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-859-3099
MAIL ADDRESS:
STREET 1: 29 NEWBURY STREET
STREET 2: SUITE 401
CITY: BOSTON
STATE: MA
ZIP: 02116
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2014-02-05
0
0001485003
Eleven Biotherapeutics, Inc.
EBIO
0001408591
THIRD ROCK VENTURES LP
29 NEWBURY STREET
BOSTON
MA
02116
0
0
1
0
0001578976
Third Rock Ventures GP, L.P.
29 NEWBURY STREET
BOSTON
MA
02116
0
0
1
0
0001578973
TRV GP, LLC
29 NEWBURY STREET
BOSTON
MA
02116
0
0
1
0
Common Stock
330708
D
Series A Preferred Stock
Common Stock
3267716
D
Series B Preferred Stock
Common Stock
481619
D
Common Stock Warrant (right to purchase)
0.0635
Common Stock
127077
D
Common Stock Warrant (right to purchase)
0.0635
Common Stock
82989
D
The Series A Preferred Stock is convertible into Common Stock on an 6.35-for-one basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering, and has no expiration date.
The general partner of Third Rock Ventures, L.P. is Third Rock Ventures GP, LP ("TRV GP"). The general partner of TRV GP is Third Rock Ventures GP, LLC ("TRV GP, LLC"). TRV GP and TRV GP, LLC disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
The Series B Preferred Stock is convertible into Common Stock on an 6.35-for-one basis into the number of shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering, and has no expiration date.
The Warrant to purchase Common Stock as shown in column 3 is exercisable at any time at the holder's election prior to June 28, 2018, and automatically upon the closing of the Issuer's initial public offering.
The Warrant to purchase Common Stock as shown in column 3 is exercisable at any time at the holder's election prior to December 4, 2018, and automatically upon the closing of the Issuer's initial public offering.
/s/ Kevin Gillis, Manager
2014-02-06
By: Third Rock Ventures GP, L.P., its general partner By: TRV GP, LLC, its general partner By: /s/ Kevin Gillis Kevin Gillis, Manager
2014-02-05
By: TRV GP, LLC, its general partner By: /s/ Kevin Gillis, Manager
2014-02-05